News

Nvidia's Bullish Trend Gathers Strength Ahead of Earnings Report

Nvidia's Bullish Trend Gathers Strength Ahead of Earnings Report

Nvidia's Momentum and Major Market Influence

As the stock market rallies to recover from previous downturns, the technology sector has significantly contributed to this positive shift. Among the standout performers, Nvidia Corp (NASDAQ: NVDA) has emerged as a leader, showcasing impressive gains since the market's turn on November 7th.

The NVDA stock has surged over 10% in just the last five days, while year-to-date performance boasts an impressive increase of nearly 44%. This rise can be attributed to the accelerating integration of artificial intelligence (AI), with more applications and uses becoming apparent.

AI is at the forefront of technological advancement, with AI agents playing a central role. The development and training of these agents demand substantial computational power, which aligns seamlessly with Nvidia's core business focus on Graphics Processing Units.

The performance of Nvidia's GPUs has significantly bolstered its recent quarterly earnings, as evidenced by a year-on-year revenue increase of 56%, bringing the total to $46.7 billion in Q2. Analysts are optimistic that Nvidia will exceed its projected revenue figures for Q3, with GPU sales continuing to be a driving force behind this growth.

Technical Trends for Nvidia Stock

Nvidia's stock is currently displaying a positive technical pattern, characterized by an ascending wedge formation. This pattern is evident on daily charts, where the stock price recently interacted with key trendline levels of $212 and $178, the latter marking a recent rebound point.

This rebound is supported by an alignment of trendlines, including a major upward resistance that has influenced prices between mid-2024 and mid-2025. Furthermore, additional trendlines have established themselves as supportive zones, reinforcing the stock price around $178.

With the stock having rebounded from these critical support levels, the current upward trend reflects one of the strongest phases experienced in recent months, cultivating positive investor sentiment as the earnings report approaches.

The sentiment surrounding Nvidia is also influenced by recent news regarding SoftBank offloading its substantial stakes in the company, valued at $5.8 billion. Following this announcement, SoftBank shares experienced a significant drop, indicating investor skepticism toward the decision.

Options Market Activity and Nvidia's Bullish Outlook

Adding to the bullish sentiment, Nvidia's current performance is reflected in the options market. The open interest surrounding NVDA options near their expiration suggests a strong inclination towards call options, demonstrated by a Put-to-Call Open Interest ratio of 0.61.

As of now, there are over 1.3 million NVDA options contracts set to expire on November 14. Among these, more than 819,000 contracts are call options, which further supports bullish expectations.

Anticipation for Earnings and Growth Prospects

In its last earnings release, Nvidia provided guidance for Q3 revenue around $54 billion, hinting at approximately 16% growth compared to the previous quarter, and a remarkable 50% increase year-on-year.

The driving force behind this growth is anticipated to be sales from data centers, projected to surpass $48 billion, supported by the expansion of its latest GPU architecture, Blackwell, aimed at high-performance AI applications.

Nvidia's CEO, Jensen Huang, recently expressed confidence regarding future sales figures, projecting over $500 billion in cumulative bookings for the Blackwell and next-generation Rubin AI chips by the end of 2026. Such positive long-term expectations, if echoed during the company's upcoming earnings call, could signal a strong bullish trend for investors.

Given the current market conditions, Nvidia's stock appears poised to retest previous highs near $212, with a possibility of breaking new records around $240 post-earnings, especially considering current forecasts that extend to $230 and expectations suggesting even higher targets for the next few years.

As analysts look ahead, the ambitious projections of $350 by 2025 seem increasingly plausible, bolstered by the favorable comments from leadership and anticipated growth trajectories.

Frequently Asked Questions

What has contributed to Nvidia's recent stock performance?

Nvidia's recent stock performance has been largely driven by significant gains in GPU sales and the increasing integration of AI technologies.

When is Nvidia's next earnings report?

Nvidia is scheduled to report its next earnings, covering Q3, on November 19.

What is the expected revenue growth for Nvidia in Q3?

Nvidia has guided for Q3 revenue around $54 billion, indicating a growth of approximately 16% from the prior quarter and about 50% year-on-year.

How are options markets affecting Nvidia's stock sentiment?

The options market is showing a bullish sentiment toward Nvidia, with a notable ratio of call options compared to puts, suggesting positive investor expectations.

What long-term projections exist for Nvidia's stock?

Analysts project Nvidia's stock could see ambitious targets, with forecasts suggesting potential prices around $350 by 2025, reflecting strong growth anticipated from new technologies and AI advancements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 185

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 176

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 207

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading

Top 5 Most Recently Viewed Articles

NVIDIA and Synopsys Forge Alliance to Transform Engineering

Updated Category News Views 137

Strategic Collaboration Between NVIDIA and Synopsys In an exciting development for the engineering and design industries, NVIDIA and Synopsys have joined forces in a strategic partnership that promises to revolutionize how these sectors operate. This collaboration aims to leverage NVIDIA's powerful computational capabilities alongside Synopsys' sophisticated engineering...

Continue Reading
EHang's Groundbreaking Pilotless Flight Marks a Historic Event

Updated Category News Views 110

EHang's Historic Pilotless Flight in Africa EHang Holdings Limited (Nasdaq: EH), a frontrunner in Urban Air Mobility (UAM), has made headlines by achieving a remarkable milestone: the first pilotless human-carrying flight of its EH216-S eVTOL aircraft in Africa. This significant event unfolded at the 9th Aviation Africa Summit in Kigali, marking a historic moment for the...

Continue Reading
Bang & Olufsen's Share Buyback: Strategic Moves for Growth

Updated Category News Views 112

Understanding Bang & Olufsen's Share Buyback Program Bang & Olufsen A/S has embarked on a significant initiative aimed at bolstering its long-term growth through its recent share buyback program. This strategic move is designed to hedge the company’s share-based long-term incentive programmes, showcasing their commitment to enhancing shareholder value. This article...

Continue Reading
Johnson & Johnson's Q2 Expectations and Analyst Ratings Insights

Updated Category News Views 275

Upcoming Earnings Announcement for Johnson & Johnson Johnson & Johnson (NYSE: JNJ) is preparing to disclose its earnings results for the upcoming second quarter. Analysts are closely watching the anticipated report, which is expected to provide valuable insights into the company's financial health. Expected Financial Performance Analyst forecasts suggest that Johnson &...

Continue Reading
Safe House Project Expands Impact with ATI Acquisition

Updated Category News Views 307

Safe House Project Expands Impact with ATI Acquisition This Giving Tuesday, the Safe House Project (SHP) shared exciting news about its acquisition of Anti-Trafficking International (ATI), an organization that has been pivotal in the fight against human trafficking. By incorporating ATI's respected practices and its renowned Just Ask Prevention Curriculum, SHP aims to...

Continue Reading